A longevity startup has dosed its first patient with a drug to reverse age-related sight loss.
Life Biosciences is testing its ER-100 drug, which has been Read Entire Article
- Homepage
- Technology
- Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Related
Canada Missed Chances to Inspect Titan Before Fatal Implosio...
11 minutes ago
0
RIGHT SIDEBAR TOP AD
Trending
Popular
Paramount-WBD merger wins approval from DOJ, source says
6 days ago
42
Fox to buy streaming device maker Roku for $22 billion
3 days ago
32
RIGHT SIDEBAR BOTTOM AD
About Us ·
Contact Us ·
Terms & Conditions ·
Privacy Policy ·
DMCA ·
Cookie Policy ·
Advertise With Us ·
© Primetweets 2026. All rights are reserved

1 week ago
29








English (US) ·